Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Escalup

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 28, 2025
Dose standardisation of intravenous anticancer drugs: Risk analysis and implementation in a French cancer centreKhevin Itoua-Gassaye, Mallory Friou, Laurence Escalup, et al.
American Journal of Clinical Oncology|July 4, 2024
Concurrent Use of Radiotherapy and Ribociclib: Preliminary Results and Review of the LiteratureJihane Bouziane, Pierre Loap, Paul Cottu, et al.
Breast (Edinburgh, Scotland)|September 18, 2016
Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in FranceAline Hurtaud, Anne Donnadieu, Laurence Escalup, et al.
International Journal of Pharmaceutics|March 8, 2013
Long-term physico-chemical stability of diluted trastuzumabMuriel Paul, Victoire Vieillard, Ricardo Da Silva Lemos, et al.
International Journal of Clinical Pharmacy|March 4, 2011
Dose standardisation of anticancer drugsAnne-Lise Pouliquen, Laurence Escalup, Nathalie Jourdan, et al.
American Journal of Clinical Oncology|July 16, 2025
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the EfficacyJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 15, 2023
Errors in prescribing injectable anticancer drugs: benefits of a pharmaceutical long-term monitoring to improve patient safety in a European comprehensive cancer centreMathilde Dupre, Laurence Escalup, Sandy Blondeel-Gomes, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 13, 2025
Gravimetric-based technology-assisted workflow system for injectable anticancer drugs compounding: Design and qualification of an original weighing scale anchored inside an isolatorMélanie Brun, Julien Fouque, Hugo Palisson, et al.
Annals of Work Exposures and Health|May 21, 2022
Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer CenterAlexandre Acramel, Julien Fouque, Sandy Blondeel-Gomes, et al.
American Journal of Clinical Oncology|July 16, 2024
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the LiteratureJihane Bouziane, Pierre Loap, Kim Cao, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 28, 2025
Dose standardisation of intravenous anticancer drugs: Risk analysis and implementation in a French cancer centreKhevin Itoua-Gassaye, Mallory Friou, Laurence Escalup, et al.
American Journal of Clinical Oncology|July 4, 2024
Concurrent Use of Radiotherapy and Ribociclib: Preliminary Results and Review of the LiteratureJihane Bouziane, Pierre Loap, Paul Cottu, et al.
Breast (Edinburgh, Scotland)|September 18, 2016
Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in FranceAline Hurtaud, Anne Donnadieu, Laurence Escalup, et al.
International Journal of Pharmaceutics|March 8, 2013
Long-term physico-chemical stability of diluted trastuzumabMuriel Paul, Victoire Vieillard, Ricardo Da Silva Lemos, et al.
International Journal of Clinical Pharmacy|March 4, 2011
Dose standardisation of anticancer drugsAnne-Lise Pouliquen, Laurence Escalup, Nathalie Jourdan, et al.
American Journal of Clinical Oncology|July 16, 2025
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the EfficacyJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 15, 2023
Errors in prescribing injectable anticancer drugs: benefits of a pharmaceutical long-term monitoring to improve patient safety in a European comprehensive cancer centreMathilde Dupre, Laurence Escalup, Sandy Blondeel-Gomes, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 13, 2025
Gravimetric-based technology-assisted workflow system for injectable anticancer drugs compounding: Design and qualification of an original weighing scale anchored inside an isolatorMélanie Brun, Julien Fouque, Hugo Palisson, et al.
Annals of Work Exposures and Health|May 21, 2022
Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer CenterAlexandre Acramel, Julien Fouque, Sandy Blondeel-Gomes, et al.
American Journal of Clinical Oncology|July 16, 2024
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the LiteratureJihane Bouziane, Pierre Loap, Kim Cao, et al.
Pageof 2